About the OTR
The Cambridge University Health Partners’ Office for Translational Research (OTR) supports researchers in their effort to translate their findings from their basic biological, biomedical or clinical research into practical human health benefits, such as new therapeutics, devices, diagnostics or other interventions. We support researchers from the Cambridge University Health Partners (CUHP):
- University of Cambridge,
- Cambridge University Hospitals NHS Foundation Trust,
- Papworth Hospital NHS Foundation Trust and
- Cambridge and Peterborough NHS Foundation Trust
How can the OTR support you?
We pro-actively work with PIs in the Cambridge University Health Partners (CUHP) Partner institutions to translate their research into interventions, therapeutics and diagnostics that will improve human health. We offer support in three major ways:
- Translational Research Projects – Development and Project Management
- Industrial Research Collaborations – Development and Co-ordination
- Large Strategic Translational/ Industrial Initiatives/ Bids – Development
There are many different sources of funding available to investigators who wish to pursue translational research. Some of these are internal strategic funds held and administered by the OTR (such as the Cambridge MRC Confidence in Concept) or other groups of the University. There are also numerous external translational funding schemes – a good selection is highlighted on Cambridge Enterprise’s website.
How can I collaborate with external partners if I’m an internal member of staff/student? How can I collaborate with Cambridge if I’m an external partner?
Are you looking for the best treatment to lower your blood pressure? If you are aged 18 to 65 years…
The Launch Event for the Experimental Medicine Training Initiative (EMI) took place at Homerton College, University of Cambridge on…
AstraZeneca and the University of Cambridge today announced three new joint schemes to support more than 80 PhD scholarships and…
Cambridge has been part of a successful £16 million bid to work with the MRC, GSK and four other UK…